Is Strattera a controlled substance? Drug class and more

STRATTERA is a selective norepinephrine reuptake inhibitor medicine. STRATTERA may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD. Administration of STRATTERA with a standard high-fat meal in adults did not affect the extent of oral absorption of atomoxetine (AUC), but did decrease the rate of absorption, resulting in a 37% lower Cmax, and delayed Tmax by 3 hours. In clinical trials with children and adolescents, administration of STRATTERA with food resulted in a 9% lower Cmax. In placebo-controlled registration studies involving pediatric patients, tachycardia was identified as an adverse event for 0.3% (5/1597) of these STRATTERA patients compared with 0% (0/934) of placebo patients.

Diagnosing ADHD in Adults

STRATTERA increased the risk of suicidal ideation in short-term studies in children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials of STRATTERA in children and adolescents have revealed a greater risk of suicidal ideation early during treatment in those receiving STRATTERA. There were a total of 12 trials (11 in ADHD and 1 in enuresis) involving over 2200 patients (including 1357 patients receiving STRATTERA and 851 receiving placebo).

More About Drugs and Medications

The elimination half-life of 4-hydroxyatomoxetine is similar to that of N-desmethylatomoxetine (6 to 8 hours) in EM subjects, while the half-life of N-desmethylatomoxetine is much longer in PM subjects (34 to 40 hours). At therapeutic concentrations, 98% of atomoxetine in plasma is bound to protein, primarily albumin. Ethnic origin did not influence atomoxetine disposition (except that PMs are more common in Caucasians). The safety, efficacy and pharmacokinetics of STRATTERA in geriatric patients have not been evaluated. Instruct patients and their caregivers to look for signs of activation of mania/hypomania see WARNINGS AND PRECAUTIONS. Advise the patient to read the FDA-approved patient labeling (Medication Guide).

Does Strattera interact with my other drugs?

Having more norepinephrine available in the brain may help improve attention and focus in people with ADHD. You may wonder how Strattera compares with other medications that are prescribed for similar uses. To find out how Strattera and Vyvanse are alike and different, see this article. If your doctor has prescribed Strattera and you’re interested in using atomoxetine instead, talk with them. You’ll also need to check your insurance plan, as it may only cover one or the other. Before approving coverage for Strattera, your insurance company may require you to get prior authorization.

They can tell you about other medications that may work well for you. It is not known whether atomoxetine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant before taking this medicine. If you are pregnant, your name may be listed on a pregnancy registry to track the effects of the active ingredient atomoxetine on the baby. Do not use this medicine if you have used an MAO inhibitor in the past 14 days. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.

Dosage for attention deficit hyperactivity disorder

He reported that this slightly improved his ability to remember what he had read and to focus on his schoolwork. At his request, the dose was increased to OROS MPH 27 mg qam with the ATX 40 mg bid. Frank has continued on this regimen for 4 months with no adverse effects.

• The time-release formulation is designed to maintain a steady level of medication in your body throughout the day.
• It may not be possible to determine whether a manic or mixed episode that appears during treatment with STRATTERA is due to an adverse reaction to STRATTERA or a patient’s underlying bipolar disorder.
• The major oxidative metabolite formed, regardless of CYP2D6 status, is 4-hydroxyatomoxetine, which is glucuronidated.
• In vitro studies suggest that coadministration of cytochrome P450 inhibitors to PMs will not increase the plasma concentrations of atomoxetine.
• To learn more, see the “Strattera precautions” section below.
• An enormous quantity of research and clinical experience has been accumulated with stimulants over the past 30 years.

Avoid storing this medication in areas where it could get damp or wet, such as bathrooms. How long a medication remains good to use can depend on many factors, including how and where you store the medication. When you get Strattera from the pharmacy, the pharmacist will add an expiration date to the label on the bottle. This date is typically 1 year from is strattera a stimulant the date they dispensed the medication. You should not open the capsules because the contents can irritate your eyes. If capsule contents accidentally come in contact with your eyes, rinse your eyes with water and seek medical advice right away.

3 Need for Comprehensive Treatment Program

• Serious reactions, including elevated blood pressure and tachyarrhythmia, have been reported in patients with pheochromocytoma or a history of pheochromocytoma who received STRATTERA.
• Drugs that inhibit CYP2D6, such as fluoxetine, paroxetine, and quinidine, cause similar increases in exposure.
• Schedule I drugs have the highest risk, and Schedule V drugs have the lowest risk.
• DailyMed will deliver this notification to your desktop, Web browser, or e-mail depending on the RSS Reader you select to use.
• However, it might take several weeks for people taking Strattera to notice its effects.
• The effects of non-stimulants, in contrast, last longer—up to 24 hours.

If recommended by your doctor, you may be able to receive a 90-day supply of Strattera, so there’s less concern about running out of the medication. If you’re interested in this option, check with your doctor, pharmacist, or insurance company. Some Medicare plans may help cover the cost of mail-order medications. Keep in mind that you may be able to get a 90-day supply of Strattera.

When you stop taking Adderall, norepinephrine and dopamine levels in the brain suddenly decrease. Dopamine is a neurotransmitter that activates the brain’s reward system, while norepinephrine plays a role in regulating cognitive functions, attention, and mood. Both Strattera and Adderall are available in different dosing ranges as well as in brand name and generic forms. Adderall tends to work quickly to relieve symptoms, while Strattera can take several weeks to reach its full efficacy.

Strattera, a non-stimulant medication, is safe and effective overall for both children and adults with ADHD. Strattera may increase the risk of suicidal thoughts among adolescents and children taking it, but it’s rare. Seek medical attention right away if you, your child, or someone you know experiences thoughts of suicide while taking Strattera. The time-release formulation is designed to maintain a steady level of medication in your body throughout the day. Your doctor may adjust your daily dosage after three days until you or your child experiences the best response — that is, the lowest dosage at which you experience the greatest improvement in symptoms without side effects.